— Know what they know.
Not Investment Advice
Also trades as: 0IDA.L (LSE) · $vol 0M

DVAX NASDAQ

Dynavax Technologies Corporation
1W: +38.2% 1M: +43.6% 3M: +49.6% 1Y: +18.3% 3Y: +42.5% 5Y: +174.6%
$15.50
Last traded 2025-12-31 — delisted
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · $1.8B mcap · 100M float · 3.15% daily turnover · Short 43% of daily vol

📊 Key Metrics

TTM
$331M
Revenue
+26.7% YoY
$-43M
Net Income
-311.9% YoY
$81M
Free Cash Flow
+255.3% YoY
84.8%
Gross Margin
22.4%
Op. Margin
28.4%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE-7.1%
ROA-4.3%
ROIC4.8%

Valuation

P/E39.7
P/B3.4
EV/EBITDA-38.7

Leverage

Debt/Equity0.53
Current Ratio7.62
Interest Cov.-5.3x

Quality Scores

Piotroski F5/9
Altman Z1.69
Beneish M-3.16

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms